ConKay Medical Systems, Inc.

medical devices

About

ConKay Medical Systems is an early-stage medical device company advancing unique solutions to treat valvular regurgitation in patients with progressive heart failure. Valvular regurgitation is when your valves do not close properly allowing blood to flow backwards in your heart causing shortness of breath, chest pain, and sometimes death. There are over 100 million people currently affected globally with valvular disease and an additional 5M Americans are diagnosed each year. ConKay's annular repair technology is designed to treat the main cause of functional regurgitation leaving the healthy leaflets intact to perform the way it was intended. We are currently focused on the Tricuspid valve. Message us for more information!

Technologies

NSOne Gmail Google Apps Squarespace ECommerce Mobile Friendly Android Node.js Remote AI

Keywords

medical equipment manufacturing structural heart disease cardiovascular devices seed investment in medtech minimally invasive heart procedures seed funding tricuspid valve therapy medical technology valve repair technology heart valve disease medtech startup medical device clinical research top cardiologist advisory board medical technology development heart valve repair device seed funding round cardiology medtech innovator finalist valvular heart disease heart disease solutions cardiac valve intervention medical device innovation minimally invasive surgery healthcare equipment & supplies seed funding for medtech valvular regurgitation treatment technology venture capital heart failure treatment heart disease treatment innovation

Location

Pleasanton, California, United States

Related Companies

Companies in the same industry